DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the CHEMBOND MATERIALTECH LTD (CHEMBOND) share price today?

CHEMBOND MATERIALTECH LTD (CHEMBOND) is trading at ₹177.4 on the NSE, up 0.24% on the day. Source: DocStoX.

What is the PE ratio of CHEMBOND MATERIALTECH LTD?

CHEMBOND MATERIALTECH LTD has a price-to-earnings (PE) ratio of 18.4 in the Chemicals sector.

What is the market capitalisation of CHEMBOND MATERIALTECH LTD?

CHEMBOND MATERIALTECH LTD has a market capitalisation of approximately ₹245 crore.

CHEMBOND MATERIALTECH LTD

CHEMBOND·NSE·Chemicals

₹177.40▲ +0.42 (+0.24%)

Chemicals · Specialty Chemicals

Revenue under pressure recently

Day₹174.10

₹180.50

52W₹105

₹22560%

Open

₹176.80

High

₹180.50

Low

₹174.10

Prev Close

₹176.98

Volume

2.3K

VWAP

₹176.93

Snapshot

Key fundamentals

Market Cap

₹245 Cr

P/E Ratio

18.44Fair

P/B Ratio

1.48

EPS

₹9.62

Book Value

₹125.00

ROE

8.84%Average

ROCE

11.00%Decent

Dividend Yield

1.11%

Debt / Equity

0.02Low

Face Value

₹5.00

52W High

₹224.90

52W Low

₹105.15

Sector

Chemicals

Industry

Specialty Chemicals

Expensive

None moatHigh uncertainty

Fair value estimate

₹133

▼ 25.1%downside

Trading at ₹177 — 25% above our estimate

BearFair valueBull

₹113₹133₹164

/100

Business quality — Watch the fundamentals

Growth 0Profitability 18Efficiency 8Valuation 89

Plain English

Our view

Revenue under pressure recently
Virtually debt-free balance sheet
Revenue has been shrinking

Strengths

Virtually debt-free balance sheet
Promoters hold a controlling stake

Risks

Revenue has been shrinking
Fundamental red flags (Piotroski 2/9)

How we got there

Fair value methods

Residual income

9% ROE fading to 13% over ~3 yrs, on ₹125 book

₹119

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹164

Analyst target

No analyst coverage

—

Blended fair value₹133

What the numbers say

Investment thesis

Bull case

Virtually debt-free balance sheet
Promoters hold a controlling stake

Bear case

Revenue has been shrinking
Fundamental red flags (Piotroski 2/9)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

18.4Fair

Below 15× is value territory; above 35× prices in strong growth

ROE

8.8%Average

Above 15% is considered healthy for Indian equities

ROCE

11.0%Decent

Above 18% means capital is working hard

Debt/Eq

0.02Low

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹245 Cr

P/B

1.48

EPS

₹9.62

Div Yield

1.11%

What changed

Recent changes

Domestic institutions+0.9% stake last quarter

What matters

News impact

Overview

Valuation

Reasonable

P/E 18.4×

Growth

Shrinking

-17% rev CAGR

Profitability

Modest

8.8% ROE

Financial health

Rock solid

D/E 0.02

Momentum

N/A

No technicals

Today

Trading activity

Delivery %—

Turnover₹4.04L Cr

Trades73

VWAP₹176.93

Face value₹5.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

-17.2%

-1.8%

10Y

-0.8%

Profit

-19.6%

-8.3%

10Y

-22.0%

EPS

-19.9%

-8.7%

10Y

-21.9%

Profile

Pros

Company is almost debt free.
Company has been maintaining a healthy dividend payout of 25.4%

Watch-outs

Cons

The company has delivered a poor sales growth of -1.82% over past five years.
Company has a low return on equity of 6.94% over last 3 years.

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 30 Jun 2026

Domestic institutions added 0.88 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

68%

Promoter

Promoters

68.1%+0.03

Public

29.7%-0.90

FII / FPI

0.6%0.00

DII

1.6%+0.88

Quarterly trend

Ownership over time

Q1 FY27

Promoter68.11%

FII0.61%

DII1.62%

Public29.68%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Incorporated in 1974, Chembond Chemicals Ltd manufactures and sells specialty chemicals and animal health products.[1]